SEARCH

SEARCH BY CITATION

References

  • 1
    Oesterling JE. Prostate specific antigen: a critical assessment of the most useful marker for adenocarcinoma of the prostate. J Urol 1991;145:907923.
  • 2
    Armbruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 1993;39:181195.
  • 3
    Lange PH, Ercole CJ, Lightner DJ, Fraley EE, Vessella R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989;141: 873879.
  • 4
    Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994; 152:13581368.
  • 5
    Takayama TK, Vessella RL, Brawer MK, Noteboom J, Lange PH. The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay. J Urol 1993;150:374378.
  • 6
    Stamey TA, Graves HCB, Wehner N, Ferrari M, Freiha FS. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol 1993;149:787792.
  • 7
    Yu H, Diamandis EP, Prestigacomo AF, Stamey TA. Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy. Clin Chem 1995;41:430434.
  • 8
    Vessella RL, Noteboom J, Lange PH. Evaluation of the automated Abbott IMx prostate specific antigen (PSA) immunoassay. Clin Chem 1992;38:20442054.
  • 9
    Prestigacomo AF, Stamey TA. Comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol 1994;152:15151519.
  • 10
    Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem 1996;42:675684.
  • 11
    Yu H, Diamandis P, Wong P, Nam R, Tachtenberg J. Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 pg/L. JUrol 1997;157:913918.
  • 12
    Witherspoon LR, Lapeyrolerie T. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. J Urol 1997;157:13221328.
  • 13
    Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, Wagner G. TNM Adas. 3rd ed. 2nd version. Berlin : Springer-Verlag, 1992.
  • 14
    Gleason DF, Mellinger GT and the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:5864.
  • 15
    Egawa S, Suyama K, Ohori M, Kawakami T, Kuwano S, Hirokado K, Hirano S, Yokoyama E, Uchida T, Koshiba K. Early detection of prostate cancer. Results of a prostate specific antigen-based detection program in Japan. Cancer 1995;76:463472.
  • 16
    Gann PH, Hennekens CH, Stampher MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA 1995;273:289294.
  • 17
    Mione R, Barichello M, Sartorello P, Leon A, Barioli P, Gion M. Third-generation PSA: ultrasensitive or ultra-precise assay Int J Biol Markers 1995;10:229235.
  • 18
    Stamey TA. Second Stanford conference on international standardization of prostate-specific antigen immunoassays:, 1994. Urology 1995;45:173184.
  • 19
    Stamey TA. Some comments on progress in the standardization of immunoassays for prostate-specific antigen. Br J Urol 1997;79(suppl):4952.
  • 20
    Schild SE, Wong WW, Novicki DE, Ferrigni RG, Swanson SK. Detection of residual prostate cancer after radical pros-taectomy with the Abbott IMx PSA assay. Urology 1996;47:878881.
  • 21
    Liedtke RJ, Kroon G, Batjer JD. Modified assay of prostate-specific antigen with a detection limit < 0.01,μg/L. Clin Chem 1993;39:21502154.
  • 22
    Witherspoon LR. Early detection of cancer relapse after prostatectomy using very sensitive prostate-specific antigen measurements. Br J Urol 1997;79(suppl):8286.
  • 23
    Kamoshida S, Tsutsumi Y. Extraprostatic localization of prostatic acid phosphatase and prostatic-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 1990;21:11081112.
  • 24
    Iwakiri J, Grandbois K, Graves HCB, Stamey TA. An analysis of urinary prostate-specific antigen before and after radical prostatectomy: evidence for secretion of prostate-specific antigen by the periurethral glands. J Urol 1993;149:783786.
  • 25
    Graves HCB. Prostate-specific antigen comes of age in diagnosis and management of prostate cancer. Clin Chem 1992;38:19301932.
  • 26
    Thompson IM. Editorial: prostate cancer. J Urol 1997;157:919920.